Bigelow Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Bigelow Investment Advisors's BMY Position: Q1 2024 in Review
Bigelow Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 6,005 shares — an estimated $308K sold.
Bigelow Investment Advisors first reported a position in BMY in Q1 2018 and held it in 20 quarters. The position peaked at $623K in Q2 2022. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.
- Bigelow Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
- Bigelow Investment Advisors sold 6,005 Bristol-Myers Squibb shares in Q1 2024, an estimated $308K.
- Bigelow Investment Advisors first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 20 quarters.
- Bigelow Investment Advisors's Bristol-Myers Squibb position peaked at $623K in Q2 2022.
- 2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.
Based on Bigelow Investment Advisors's 13F filing for Q1 2024, filed 8 May 2024.